A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04717-w ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von N de Rouw und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Radboudumc, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Pemetrexed, Cystatin C, Creatinine, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Introduction
For drugs with a narrow therapeutic window, there is a delicate balance between efficacy and toxicity, thus it is pivotal to administer the right dose from the first administration onwards. Exposure of pemetrexed, a cytotoxic drug used in lung cancer treatment, is dictated by kidney function. To facilitate optimized dosing of pemetrexed, accurate prediction of drug clearance is pivotal. Therefore, the aim of this study was to investigate the performance of the kidney function biomarkers serum creatinine, cystatin C and pro-enkephalin in terms of predicting the elimination of pemetrexed.
Methods
We performed a population pharmacokinetic analysis using a dataset from two clinical trials containing pharmacokinetic data of pemetrexed and measurements of all three biomarkers. A three-compartment model without covariates was fitted to the data and the obtained individual empirical Bayes estimates for pemetrexed clearance were considered the “true” values (Cl true ). Subsequently, the following algorithms were tested as covariates for pemetrexed clearance: the Chronic Kidney Disease Epidemiology Collaboration equation using creatinine (CKD-EPI CR ), cystatin C (CKD-EPI CYS ), a combination of both (CKD-EPI CR-CYS ), pro-enkephalin as an absolute value or in a combined algorithm with age and serum creatinine, and lastly, a combination of pro-enkephalin with cystatin C.
Results
The dataset consisted of 66 subjects with paired observations for all three kidney function biomarkers. Inclusion of CKD-EPI CR-CYS as a covariate on pemetrexed clearance resulted in the best model fit, with the largest decrease in objective function (p < 0.00001) and explaining 35% of the total inter-individual variability in clearance. The predictive performance of the model to containing CKD-EPI CR-CYS to predict pemetrexed clearance was good with a normalized root mean squared error and mean prediction error of 19.9% and 1.2%, respectively.
Conclusions
In conclusion, this study showed that the combined CKD-EPI CR-CYS performs best in terms predicting pharmacokinetics of pemetrexed. Despite the hypothesized disadvantages, creatinine remains to be a suitable and readily available marker to predict pemetrexed clearance in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Radboudumc, Nijmegen, The Netherlands.
- Department of Pharmacy, Amphia Hospital, Breda, The Netherlands.
- Department of Intensive Care Medicine, Radboudumc, Nijmegen, The Netherlands.
- Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, The Netherlands.
- Radboud Institute Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
- SphingoTec GmbH, Hennigsdorf, Germany.
Förderung
- ZonMw
Zitieren
APA
de Rouw, N., Beunders, R., Hartmann, O., Schulte, J., Boosman, R. J., Derijks, H. J., Burger, D. M., van den Heuvel, M. M., Hilbrands, L. B., Pickkers, P., & Ter Heine, R. (2024). A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04717-w
Vancouver
de Rouw N, Beunders R, Hartmann O, Schulte J, Boosman RJ, Derijks HJ, et al. A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04717-w
BibTeX
@article{deRouw2024,
author = {de Rouw, N and Beunders, R and Hartmann, O and Schulte, J and Boosman, R J and Derijks, H J and Burger, D M and van den Heuvel, M M and Hilbrands, L B and Pickkers, P and Ter Heine, R},
title = {A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04717-w}
}
EUVIMED